CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 89 filers reported holding CUREVAC N V in Q1 2024. The put-call ratio across all filers is 4.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $393,255 | -69.3% | 129,787 | -57.3% | 0.00% | -100.0% |
| Q4 2023 | $1,279,246 | -38.5% | 303,859 | -0.2% | 0.00% | -50.0% |
| Q3 2023 | $2,079,954 | -32.7% | 304,532 | +2.6% | 0.00% | -33.3% |
| Q2 2023 | $3,092,145 | +79.9% | 296,751 | +20.3% | 0.00% | +50.0% |
| Q1 2023 | $1,718,899 | +43.4% | 246,614 | +24.0% | 0.00% | +100.0% |
| Q4 2022 | $1,198,921 | -7.9% | 198,826 | +20.3% | 0.00% | 0.0% |
| Q3 2022 | $1,302,000 | -13.8% | 165,209 | +48.9% | 0.00% | -50.0% |
| Q2 2022 | $1,510,000 | +41.3% | 110,973 | +103.6% | 0.00% | +100.0% |
| Q1 2022 | $1,069,000 | -23.1% | 54,498 | +34.6% | 0.00% | 0.0% |
| Q4 2021 | $1,390,000 | -67.2% | 40,489 | -47.8% | 0.00% | -50.0% |
| Q3 2021 | $4,238,000 | +189.3% | 77,582 | +289.0% | 0.00% | +100.0% |
| Q2 2021 | $1,465,000 | – | 19,942 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 3,134,780 | $230,000,000 | 35.34% |
| Affinity Asset Advisors, LLC | 150,000 | $11,022,000 | 3.95% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 132,300 | $9,722,000 | 0.79% |
| Renaissance Capital LLC | 56,915 | $4,182,000 | 0.66% |
| QCM Cayman, Ltd. | 2,744 | $202,000 | 0.52% |
| Green Alpha Advisors, LLC | 4,545 | $334,000 | 0.23% |
| Baillie Gifford | 5,515,262 | $405,261,000 | 0.20% |
| CSS LLC/IL | 60,000 | $4,408,000 | 0.18% |
| Caption Management, LLC | 161,400 | $11,860,000 | 0.16% |
| MANGROVE PARTNERS IM, LLC | 20,200 | $1,484,000 | 0.15% |